Pursuing Charlene's Dream

Article

Oncology nursing is more than just a job to Barbara Bittner, RN, OCN.

Barbara Bittner, RN, OCN, is an oncology nurse navigator at AdventHealth in Florida. But to her, nursing is much more than just a career. Bittner cares deeply for all of her patients, and even helped establish Charlene's Dream, a resource center for women with cancer, after her friend and Colleague, Charlene, passed away from the disease.

Recent Videos
a woman sitting in front of a green wall with a white top and glasses
a woman sitting in front of a CURE Background with a black and floral top
a woman with a white shirt and glasses sitting in front of a green wall.
Related Content
Simple illustration of the gastrointestinal track on a light blue background

Cabozantinib Lengthens PFS for Extrapancreatic NETs of GI Origin

Megan Hollasch
January 24th 2025
Article

Cabozantinib prolonged PFS compared to placebo for patients with extrapancreatic NETs starting in the GI tract in a subgroup analysis of the CABINET trial.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

test tubes, one of which is being held by a person with a white lab coat

22% of Community Providers Reported Biomarker Testing in Gastric/GEJ Cancers

Bridget Hoyt
January 24th 2025
Article

Findings from this survey also demonstrated that 23% of providers were comfortable with interpreting biomarker testing results for treatment decision-making.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

dark outline of a body with an esophagus featuring a red dot

Tislelizumab Plus Chemotherapy Demonstrates Strong Anti-Tumor Activity in ESCC

Courtney Flaherty
January 24th 2025
Article

The phase 3 RATIONALE-306 study found no significant difference in overall survival benefits from tislelizumab plus chemotherapy between early and late responders with ESCC.

dark blue outline indicating the gastrointestinal system

Nivolumab/Chemo Shows Lasting Benefit in Advanced Gastroesophageal Cancers

Jason Broderick
January 23rd 2025
Article

Five-year data shows lasting benefit for patients with advanced gastroesophageal cancers treated with nivolumab and chemotherapy.